VRAX — Virax Biolabs Share News
0.000.00%
Last trade - 00:00- $1.62m
- -$4.65m
- $0.01m
Biotech stocks jump after Moderna, Merck's melanoma vaccine succeeds in large trial
NASDAQ RESUMED AT 02:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:36 PM
NASDAQ RESUMED AT 10:21 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
NASDAQ RESUMED AT 12:10 PM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 12:04 PM
NASDAQ RESUMED AT 12:02 PM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 11:39 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Announces 1-For-25 Share Consolidation
Brief: Virax Biolabs Partners With Emory University On Viraximmune™ Clinical Studies
Brief: Virax Biolabs Group Appoints Iain Miller, Phd As Independent Director To Accelerate Commercial Strategy
Brief: Virax Biolabs Group CFO Jason Davis To Resign
U.S. STOCKS ON THE MOVE-Gold miners, Hut 8, Mr Cooper Group